Methylation profiling and evaluation of demethylating therapy in renal cell carcinoma

BACKGROUND: Despite therapeutic advances in targeted therapy, metastatic renal cell carcinoma (RCC) remains incurable for the vast majority of patients. Key molecular events in the pathogenesis of RCC include inactivation of the VHL tumour suppressor gene (TSG), inactivation of chromosome 3p TSGs im...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Ricketts, Christopher J, Morris, Mark R, Gentle, Dean, Shuib, Salwati, Brown, Michael, Clarke, Noel, Wei, Wenbin, Nathan, Paul, Latif, Farida, Maher, Eamonn R
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2013
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3848591/
https://ncbi.nlm.nih.gov/pubmed/24034811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1868-7083-5-16
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki